Cronos Group Inc. (NASDAQ:CRON) shares, rose in value on Thursday, Apr 08, with the stock price up by 1.42% to the previous day’s close as strong demand from buyers drove the stock to $8.83.
Actively observing the price movement in the recent trading, the stock is buoying the session at $8.71, falling within a range of $8.55 and $8.87. The value of beta (5-year monthly) is 0 whereas the PE ratio is 0 over 12-month period. Referring to stock’s 52-week performance, its high was $15.83, and the low was $4.62. On the whole, CRON has fluctuated by -7.73% over the past month.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that CRON’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium term indicators have put the stock in the category of 50% Buy while long term indicators on average have been pointing out that it is a 50% Buy.
11 analyst(s) have assigned their ratings of the stock’s forecast evaluation on a scale of 1.00-5.00 to indicate a strong buy to a strong sell recommendation. The stock is rated as a Hold by 7 analyst(s), no one recommend it as a Buy and 1 called the CRON stock Outperform. In the meantime, 2 analyst(s) believe the stock as Underperform and 1 think it is a Sell. Thus, investors eager to increase their holdings of the company’s stock will have an opportunity to do so as the average rating for the stock is Hold.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of CRON currently trading nearly -8.67% and -17.44% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 38.27, while the 7-day volatility ratio is showing 4.13% which for the 30-day chart, stands at 5.29%. Furthermore, Cronos Group Inc. (CRON)’s beta value is 0, and its average true range (ATR) is 0.55. The company’s stock has been forecasted to trade at an average price of $8.65 over the course of the next 52 weeks, with a low of $5.92 and a high of $11.06. Based on these price targets, the low is -32.96 off current price, whereas the price has to move +25.25% to reach the yearly target high. Additionally, analysts’ median price of $9 is likely to be welcomed by investors because it represents an increase of +1.93% from the current levels.
A comparison of Cronos Group Inc. (CRON) with its peers suggests the former has fared considerably better in the market. CRON showed an intraday change of +1.42% in today’s session so far, and over the past year, it grew by +50.95%. In comparison, Zoetis Inc Cl A (ZTS) has moved higher at +1.32% today and is up +24.52% over the past 12 months. On the other hand, the price of Takeda Pharmaceutical Co. Ltd (TAK) has fallen -1.33% today. The stock, however, is off 11.87% from where it was a year ago. Additionally, there is a gain of 142% for Catalent Inc (CTLT) in recent trading while the stock has seen an overall apprecation of 50.95% over the past year. The PE ratio stands at 0 for Cronos Group Inc., compared to 46.12 for Zoetis Inc Cl A, and 33.19 for Takeda Pharmaceutical Co. Ltd. Other than that, the overall performance of the S&P 500 during the today’s session so far shows that it gained 0.29%. Meanwhile, the Dow Jones Industrial weakened by -0.03%.
Data on historical trading for Cronos Group Inc. (NASDAQ:CRON) indicates that the trading volumes over the past 10 days have averaged 2.46 Million and over the past 3 months, they’ve averaged 6.48 Million. According to company’s latest data on outstanding shares, there are 360.26 Million shares outstanding.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Nearly 50.77% of Cronos Group Inc.’s shares belong to company insiders and institutional investors own 14.79% of the company’s shares, according to Thomson Reuters’ data. The data on short interest also indicates that stock shorts accounted for 23.67 Million shares as on March 14, 2021, resulting in a short ratio of 4.58. According to the data, the short interest in Cronos Group Inc. (CRON) stood at 6.57% of shares outstanding as of March 14, 2021; the number of short shares registered in February reached 25.94 Million. The stock has risen by +25.5% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CRON stock heading into the next quarter.